Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.7275 EUR -1.09%
Market Cap: 493.5m EUR
Have any thoughts about
Pharming Group NV?
Write Note

Pharming Group NV
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharming Group NV
Total Equity Peer Comparison

Comparables:
PRQR
QURE
ARGX
MRUS
LVTX

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Pharming Group NV
AEX:PHARM
Total Equity
$225.8m
CAGR 3-Years
11%
CAGR 5-Years
20%
CAGR 10-Years
30%
ProQR Therapeutics NV
NASDAQ:PRQR
Total Equity
€32.9m
CAGR 3-Years
-35%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Total Equity
$55.8m
CAGR 3-Years
-54%
CAGR 5-Years
-31%
CAGR 10-Years
-1%
argenx SE
XBRU:ARGX
Total Equity
$4.3B
CAGR 3-Years
13%
CAGR 5-Years
45%
CAGR 10-Years
71%
Merus NV
NASDAQ:MRUS
Total Equity
$703.3m
CAGR 3-Years
51%
CAGR 5-Years
56%
CAGR 10-Years
N/A
LAVA Therapeutics NV
NASDAQ:LVTX
Total Equity
$51.2m
CAGR 3-Years
89%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharming Group NV's Total Equity?
Total Equity
225.8m USD

Based on the financial report for Sep 30, 2024, Pharming Group NV's Total Equity amounts to 225.8m USD.

What is Pharming Group NV's Total Equity growth rate?
Total Equity CAGR 10Y
30%

Over the last year, the Total Equity growth was 8%. The average annual Total Equity growth rates for Pharming Group NV have been 11% over the past three years , 20% over the past five years , and 30% over the past ten years .

Back to Top